Vir Biotechnology opens new office in St. Louis - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 68%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

A San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis.

, Vir’s senior vice president of microbiology and virology and St. Louis site head, said the company’s new local office will focus on research and development, supporting pre-clinical testing to advance and commercialize its drug pipeline. Purcell said St. Louis' new office gives it proximity to research institutions and collaborators like Saint Louis University and Washington University and places it within a “thriving bioscience community.”Vir announced its St.

Scroll through the gallery above to take a look inside Vir's new office in the Cortex innovation district. Vir tapped HOK as architect for its new St. Louis office, with Tarlton Corp. acting as general contractor. Several local economic development groups said they were involved in securing Vir’s St. Louis expansion, including Greater St. Louis Inc., Missouri Partnership, Missouri Department of Economic Development, St. Louis Economic Development Partnership and St. Louis Development Corporation. As part of its expansion, Vir is eligible to receive state incentives though Missouri Works Program, which helps businesses access capital through withholdings or tax credits.

 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 78. in İR

ایران آخرین اخبار, ایران سرفصلها

Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.

Vir Biotechnology opens new office in St. Louis - San Francisco Business TimesThe San Francisco-based immunology company that wants to help eradicate infectious disease globally has expanded its footprint in St. Louis, opening a new $41 million office within the Cortex innovation district. It says the new facility will be critical to advancing research to treat several infectious diseases, including Covid-19.
منبع: SFBusinessTimes - 🏆 78. / 68 ادامه مطلب »